|
Volumn 371, Issue 5, 2014, Pages 480-481
|
Dr. Kastner and colleagues reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARGININE;
CELL PROTEIN;
FRESH FROZEN PLASMA;
GLUTAMINE;
INTERLEUKIN 6;
PROTEIN ADA2;
TUMOR NECROSIS FACTOR ANTIBODY;
UNCLASSIFIED DRUG;
ADENOSINE DEAMINASE;
SIGNAL PEPTIDE;
ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA;
BONE MARROW CELL;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
CECR1 GENE;
CELL LINEAGE;
ENZYME DEFICIENCY;
ENZYME REPLACEMENT;
FAMILIAL DISEASE;
FEVER;
GENE;
GENE MUTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HOMOZYGOTE;
HUMAN;
HUMAN HERPESVIRUS 8;
INTERLEUKIN 6 BLOOD LEVEL;
LETTER;
MACROPHAGE;
MONOCYTE;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
SNEDDON SYNDROME;
ANIMAL;
CEREBROVASCULAR ACCIDENT;
DEFICIENCY;
FEMALE;
GENETICS;
MALE;
MUTATION;
POLYARTERITIS NODOSA;
VASCULAR DISEASE;
ADENOSINE DEAMINASE;
ANIMALS;
FEMALE;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
MALE;
MUTATION;
POLYARTERITIS NODOSA;
STROKE;
VASCULAR DISEASES;
|
EID: 84904863846
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1405506 Document Type: Letter |
Times cited : (14)
|
References (6)
|